ImageneBio, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 10, 2026 (15 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 21, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| May 11, 2026 | Wedbush | reiterate | Underperform → Underperform | — | 58% |
| Oct 24, 2025 | Leerink Partners | initiate | — → Outperform | $30 | 51% |
No cross-platform signals in the last 90 days